292 related articles for article (PubMed ID: 15507538)
1. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E486-92. PubMed ID: 15507538
[TBL] [Abstract][Full Text] [Related]
2. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.
Granado M; Martín AI; López-Menduiña M; López-Calderón A; Villanúa MA
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E131-41. PubMed ID: 17986630
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.
Laferrère B; Abraham C; Russell CD; Bowers CY
J Clin Endocrinol Metab; 2005 Feb; 90(2):611-4. PubMed ID: 15699539
[TBL] [Abstract][Full Text] [Related]
5. The positive effects of growth hormone-releasing peptide-6 on weight gain and fat mass accrual depend on the insulin/glucose status.
Granado M; García-Cáceres C; Frago LM; Argente J; Chowen JA
Endocrinology; 2010 May; 151(5):2008-18. PubMed ID: 20219977
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
[TBL] [Abstract][Full Text] [Related]
7. Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake.
Laferrère B; Hart AB; Bowers CY
Obesity (Silver Spring); 2006 Jun; 14(6):1056-63. PubMed ID: 16861611
[TBL] [Abstract][Full Text] [Related]
8. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
Thomas GB; Fairhall KM; Robinson IC
Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
[TBL] [Abstract][Full Text] [Related]
9. Effects of captopril on interleukin-6, leukotriene B(4), and oxidative stress markers in serum and inflammatory exudate of arthritic rats: evidence of antiinflammatory activity.
Agha AM; Mansour M
Toxicol Appl Pharmacol; 2000 Oct; 168(2):123-30. PubMed ID: 11032767
[TBL] [Abstract][Full Text] [Related]
10. Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis.
Suke SG; Negi H; Mediratta PK; Banerjee BD; Sharma KK
Eur J Pharmacol; 2013 Oct; 718(1-3):57-62. PubMed ID: 24075936
[TBL] [Abstract][Full Text] [Related]
11. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice.
De Winter BY; De Man JG; Seerden TC; Depoortere I; Herman AG; Peeters TL; Pelckmans PA
Neurogastroenterol Motil; 2004 Aug; 16(4):439-46. PubMed ID: 15305999
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.
Depoortere I; De Winter B; Thijs T; De Man J; Pelckmans P; Peeters T
Eur J Pharmacol; 2005 May; 515(1-3):160-8. PubMed ID: 15890336
[TBL] [Abstract][Full Text] [Related]
13. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism.
Bhatti SF; De Vliegher SP; Van Ham L; Kooistra HS
Mol Cell Endocrinol; 2002 Nov; 197(1-2):97-103. PubMed ID: 12431802
[TBL] [Abstract][Full Text] [Related]
14. Feeding response to ghrelin agonist and antagonist in lean and obese Zucker rats.
Beck B; Richy S; Stricker-Krongrad A
Life Sci; 2004 Dec; 76(4):473-8. PubMed ID: 15530508
[TBL] [Abstract][Full Text] [Related]
15. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
16. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children.
Mericq V; Cassorla F; Bowers CY; Avila A; Gonen B; Merriam GR
J Pediatr Endocrinol Metab; 2003 Sep; 16(7):981-5. PubMed ID: 14513874
[TBL] [Abstract][Full Text] [Related]
17. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
Lawrence CB; Snape AC; Baudoin FM; Luckman SM
Endocrinology; 2002 Jan; 143(1):155-62. PubMed ID: 11751604
[TBL] [Abstract][Full Text] [Related]
18. Hecogenin exhibits anti-arthritic activity in rats through suppression of pro-inflammatory cytokines in Complete Freund's adjuvant-induced arthritis.
Ingawale DK; Patel SS
Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):59-71. PubMed ID: 29192804
[TBL] [Abstract][Full Text] [Related]
19. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.
Tschöp M; Flora DB; Mayer JP; Heiman ML
Obes Res; 2002 Oct; 10(10):991-9. PubMed ID: 12376579
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
Gomez-Sanmiguel AB; Nieto-Bona MP; Fernandez-Galaz C; Priego T; Martin AI; Lopez-Calderon A
J Physiol Pharmacol; 2017 Apr; 68(2):191-199. PubMed ID: 28614768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
